Introduction: Although both patients with kidney failure (KF) receiving hemodialysis (HD) and kidney transplantation (KT) recipients (KTRs) have a high risk of bladder cancer, how this risk changes in the transition from dialysis to KT is unknown. In this study, we aimed to investigate the risk of bladder cancer in KTRs and patients on HD. Methods: This was a nationwide longitudinal cohort study of 66,547 participants from the National Health Insurance Service cohort who started HD for patients with KF or who received KT from 2002 to 2020. The primary outcome was the diagnosis of bladder cancer, which was defined as the composite of diagnostic codes and either hospitalization or ≥2 outpatient visits for bladder cancer. Results: During mean follow-ups of 4.2 and 7.9 years in the HD and KT groups, respectively, the incidence rates of bladder cancer were 1.1/1,000 and 0.3/1,000 person-years, respectively. In the time-dependent multivariable Cox models, compared to patients on HD, the adjusted hazard ratio (aHR) for bladder cancer among KTRs was 0.36 (95% confidence interval [CI], 0.21–0.60; p < 0.001). Among men, this aHR was 0.29 (95% CI, 0.15–0.55; p < 0.001); however, no statistically significant association between the kidney replacement therapy modality and the risk of bladder cancer was observed among women. Landmark analysis performed to avoid immortal time bias by redefining time zero as a specific landmark time (2 and 5 years after HD initiation or KT) revealed similar results. Conclusion: The risk of bladder cancer was significantly lower among KTRs than that among patients receiving HD, particularly among men.

1.
GBD Chronic Kidney Disease Collaboration
.
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
.
Lancet
.
2020
;
395
(
10225
):
709
33
.
2.
Maisonneuve
P
,
Agodoa
L
,
Gellert
R
,
Stewart
JH
,
Buccianti
G
,
Lowenfels
AB
, et al
.
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
.
Lancet
.
1999
;
354
(
9173
):
93
9
.
3.
Butler
AM
,
Olshan
AF
,
Kshirsagar
AV
,
Edwards
JK
,
Nielsen
ME
,
Wheeler
SB
, et al
.
Cancer incidence among US Medicare ESRD patients receiving hemodialysis, 1996-2009
.
Am J Kidney Dis
.
2015
;
65
(
5
):
763
72
.
4.
Hong
YA
,
Ban
TH
,
Kang
CY
,
Hwang
SD
,
Choi
SR
,
Lee
H
, et al
.
Trends in epidemiologic characteristics of end-stage renal disease from 2019 Korean Renal Data System (KORDS)
.
Kidney Res Clin Pract
.
2021
;
40
(
1
):
52
61
.
5.
Wolfe
RA
,
Ashby
VB
,
Milford
EL
,
Ojo
AO
,
Ettenger
RE
,
Agodoa
LY
, et al
.
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant
.
N Engl J Med
.
1999
;
341
(
23
):
1725
30
.
6.
Hariharan
S
,
Johnson
CP
,
Bresnahan
BA
,
Taranto
SE
,
McIntosh
MJ
,
Stablein
D
.
Improved graft survival after renal transplantation in the United States, 1988 to 1996
.
N Engl J Med
.
2000
;
342
(
9
):
605
12
.
7.
Lim
K
,
Ting
SMS
,
Hamborg
T
,
McGregor
G
,
Oxborough
D
,
Tomkins
C
, et al
.
Cardiovascular functional reserve before and after kidney transplant
.
JAMA Cardiol
.
2020
;
5
(
4
):
420
9
.
8.
Blosser
CD
,
Haber
G
,
Engels
EA
.
Changes in cancer incidence and outcomes among kidney transplant recipients in the United States over a thirty-year period
.
Kidney Int
.
2021
;
99
(
6
):
1430
8
.
9.
Ying
T
,
Shi
B
,
Kelly
PJ
,
Pilmore
H
,
Clayton
PA
,
Chadban
SJ
.
Death after kidney transplantation: an analysis by era and time post-transplant
.
J Am Soc Nephrol
.
2020
;
31
(
12
):
2887
99
.
10.
Villeneuve
PJ
,
Schaubel
DE
,
Fenton
SS
,
Shepherd
FA
,
Jiang
Y
,
Mao
Y
.
Cancer incidence among Canadian kidney transplant recipients
.
Am J Transpl
.
2007
;
7
(
4
):
941
8
.
11.
Siegel
RL
,
Miller
KD
,
Jemal
A
.
Cancer statistics, 2020
.
CA Cancer J Clin
.
2020
;
70
(
1
):
7
30
.
12.
Dantal
J
,
Hourmant
M
,
Cantarovich
D
,
Giral
M
,
Blancho
G
,
Dreno
B
, et al
.
Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens
.
Lancet
.
1998
;
351
(
9103
):
623
8
.
13.
Ou
JH
,
Pan
CC
,
Lin
JS
,
Tzai
TS
,
Yang
WH
,
Chang
CC
, et al
.
Transitional cell carcinoma in dialysis patients
.
Eur Urol
.
2000
;
37
(
1
):
90
4
.
14.
Chang
CH
,
Yang
CM
,
Yang
AH
.
Renal diagnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwan
.
Cancer
.
2007
;
109
(
8
):
1487
92
.
15.
Brooks
ER
,
Siriruchatanon
M
,
Prabhu
V
,
Charytan
DM
,
Huang
WC
,
Chen
Y
, et al
.
Chronic kidney disease and risk of kidney or urothelial malignancy: systematic review and meta-analysis
.
Nephrol Dial Transpl
.
2024
;
39
(
6
):
1023
33
.
16.
Lin
HF
,
Li
YH
,
Wang
CH
,
Chou
CL
,
Kuo
DJ
,
Fang
TC
.
Increased risk of cancer in chronic dialysis patients: a population-based cohort study in Taiwan
.
Nephrol Dial Transpl
.
2012
;
27
(
4
):
1585
90
.
17.
Hickman
LA
,
Sawinski
D
,
Guzzo
T
,
Locke
JE
.
Urologic malignancies in kidney transplantation
.
Am J Transpl
.
2018
;
18
(
1
):
13
22
.
18.
Seong
SC
,
Kim
YY
,
Park
SK
,
Khang
YH
,
Kim
HC
,
Park
JH
, et al
.
Cohort profile: the national health insurance service-national health screening cohort (NHIS-heals) in Korea
.
BMJ Open
.
2017
;
7
(
9
):
e016640
.
19.
Quan
H
,
Li
B
,
Couris
CM
,
Fushimi
K
,
Graham
P
,
Hider
P
, et al
.
Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries
.
Am J Epidemiol
.
2011
;
173
:
676
82
.
20.
Wang
Y
,
Lan
GB
,
Peng
FH
,
Xie
XB
.
Cancer risks in recipients of renal transplants: a meta-analysis of cohort studies
.
Oncotarget
.
2018
;
9
(
20
):
15375
85
.
21.
Kim
B
,
Kang
M
,
Kim
Y
,
Lee
HS
,
Kim
B
,
Lee
JJ
, et al
.
De novo cancer incidence after kidney transplantation in South Korea from 2002 to 2017
.
J Clin Med
.
2021
;
10
(
16
):
3530
.
22.
Jung
SW
,
Lee
H
,
Cha
JM
.
Risk of malignancy in kidney transplant recipients: a nationwide population-based cohort study
.
BMC Nephrol
.
2022
;
23
(
1
):
160
.
23.
Kim
JH
,
Kim
SO
,
Han
DJ
,
Park
SK
.
Post-transplant malignancy: a burdensome complication in renal allograft recipients in Korea
.
Clin Transpl
.
2014
;
28
(
4
):
434
42
.
24.
Li
WH
,
Chen
YJ
,
Tseng
WC
,
Lin
MW
,
Chen
TJ
,
Chu
SY
, et al
.
Malignancies after renal transplantation in Taiwan: a nationwide population-based study
.
Nephrol Dial Transpl
.
2012
;
27
(
2
):
833
9
.
25.
Cheung
CY
,
Lam
MF
,
Chu
KH
,
Chow
KM
,
Tsang
KY
,
Yuen
SK
, et al
.
Malignancies after kidney transplantation: Hong Kong renal registry
.
Am J Transpl
.
2012
;
12
(
11
):
3039
46
.
26.
Wu
MJ
,
Lian
JD
,
Yang
CR
,
Cheng
CH
,
Chen
CH
,
Lee
WC
, et al
.
High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan
.
Am J Kidney Dis
.
2004
;
43
(
6
):
1091
7
.
27.
Sung
H
,
Ferlay
J
,
Siegel
RL
,
Laversanne
M
,
Soerjomataram
I
,
Jemal
A
, et al
.
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
.
CA Cancer J Clin
.
2021
;
71
(
3
):
209
49
.
28.
Cook
MB
,
McGlynn
KA
,
Devesa
SS
,
Freedman
ND
,
Anderson
WF
.
Sex disparities in cancer mortality and survival
.
Cancer Epidemiol Biomarkers Prev
.
2011
;
20
(
8
):
1629
37
.
29.
Doshi
B
,
Athans
SR
,
Woloszynska
A
.
Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions
.
Oncogenesis
.
2023
;
12
(
1
):
44
.
30.
Freedman
ND
,
Silverman
DT
,
Hollenbeck
AR
,
Schatzkin
A
,
Abnet
CC
.
Association between smoking and risk of bladder cancer among men and women
.
JAMA
.
2011
;
306
(
7
):
737
45
.
31.
Jamal
A
,
King
BA
,
Neff
LJ
,
Whitmill
J
,
Babb
SD
,
Graffunder
CM
.
Current cigarette smoking among adults: United States, 2005-2015
.
MMWR Morb Mortal Wkly Rep
.
2016
;
65
(
44
):
1205
11
.
32.
Peters
SAE
,
Huxley
RR
,
Woodward
M
.
Do smoking habits differ between women and men in contemporary Western populations? Evidence from half a million people in the UK Biobank study
.
BMJ Open
.
2014
;
4
(
12
):
e005663
.
33.
Gunter
R
,
Szeto
E
,
Jeong
SH
,
Suh
S
,
Waters
AJ
.
Cigarette smoking in South Korea: a narrative review
.
Korean J Fam Med
.
2020
;
41
(
1
):
3
13
.
34.
Banas
MC
,
Banas
B
,
Wolf
J
,
Hoffmann
U
,
Krüger
B
,
Böger
CA
, et al
.
Smoking behaviour of patients before and after renal transplantation
.
Nephrol Dial Transpl
.
2008
;
23
(
4
):
1442
6
.
35.
Ark
JT
,
Alvarez
JR
,
Koyama
T
,
Bassett
JC
,
Blot
WJ
,
Mumma
MT
, et al
.
Variation in the diagnostic evaluation among persons with hematuria: influence of gender, race and risk factors for bladder cancer
.
J Urol
.
2017
;
198
(
5
):
1033
8
.
36.
Garg
T
,
Pinheiro
LC
,
Atoria
CL
,
Donat
SM
,
Weissman
JS
,
Herr
HW
, et al
.
Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis
.
J Urol
.
2014
;
192
(
4
):
1072
7
.
37.
Bouman
A
,
Schipper
M
,
Heineman
MJ
,
Faas
MM
.
Gender difference in the non-specific and specific immune response in humans
.
Am J Reprod Immunol
.
2004
;
52
(
1
):
19
26
.
38.
Girón-González
JA
,
Moral
FJ
,
Elvira
J
,
García-Gil
D
,
Guerrero
F
,
Gavilán
I
, et al
.
Consistent production of a higher TH1:TH2 cytokine ratio by stimulated T cells in men compared with women
.
Eur J Endocrinol
.
2000
;
143
(
1
):
31
6
.
39.
Luo
Y
,
Henning
J
,
O’Donnell
MA
.
Th1 cytokine-secreting recombinant Mycobacterium bovis Bacillus calmette-guérin and prospective use in immunotherapy of bladder cancer
.
Clin Dev Immunol
.
2011
;
2011
:
728930
.
40.
Vajdic
CM
,
McDonald
SP
,
McCredie
MR
,
van Leeuwen
MT
,
Stewart
JH
,
Law
M
, et al
.
Cancer incidence before and after kidney transplantation
.
JAMA
.
2006
;
296
(
23
):
2823
31
.
41.
Birkeland
SA
,
Løkkegaard
H
,
Storm
HH
.
Cancer risk in patients on dialysis and after renal transplantation
.
Lancet
.
2000
;
355
(
9218
):
1886
7
.
42.
Kawahara
T
,
Kashiwagi
E
,
Ide
H
,
Li
Y
,
Zheng
Y
,
Miyamoto
Y
, et al
.
Cyclosporine A and tacrolimus inhibit bladder cancer growth through down-regulation of NFATc1
.
Oncotarget
.
2015
;
6
(
3
):
1582
93
.
43.
Lee
HS
,
Kang
M
,
Kim
B
,
Park
Y
.
Outcomes of kidney transplantation over a 16-year period in Korea: an analysis of the national health information database
.
PLoS One
.
2021
;
16
(
2
):
e0247449
.
You do not currently have access to this content.